Hemagen Diagnostics Inc
Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its human diagnostics products also comprise Universal IFA components; supplies, controls… Read more
Hemagen Diagnostics Inc (HMGN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2012: 0.014x
Based on the latest financial reports, Hemagen Diagnostics Inc (HMGN) has a cash flow conversion efficiency ratio of 0.014x as of September 2012.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-50.84K) by net assets ($-3.56 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hemagen Diagnostics Inc - Cash Flow Conversion Efficiency Trend (1993–2012)
This chart illustrates how Hemagen Diagnostics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Hemagen Diagnostics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hemagen Diagnostics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Halitron Inc
PINK:HAON
|
-0.490x |
|
Hawk Systems Inc
PINK:HWSY
|
0.113x |
|
China Electronics Holdings Inc
PINK:MSBN
|
-0.011x |
|
Zulu-Tek Inc
PINK:ZULU
|
N/A |
|
Roboserver Systems Corp
PINK:RBSY
|
0.042x |
|
Associates First Capital Corp
PINK:ASFZ
|
0.018x |
|
Crumbs Bake Shop Inc
PINK:CRMBQ
|
1.190x |
|
Bourque Indts Inc
PINK:BORK
|
-0.088x |
Annual Cash Flow Conversion Efficiency for Hemagen Diagnostics Inc (1993–2012)
The table below shows the annual cash flow conversion efficiency of Hemagen Diagnostics Inc from 1993 to 2012.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2012-09-30 | $-3.56 Million | $-358.69K | 0.101x | -19.63% |
| 2011-09-30 | $-2.69 Million | $-337.17K | 0.125x | +26.52% |
| 2010-09-30 | $-1.85 Million | $-183.18K | 0.099x | +1150.55% |
| 2009-09-30 | $-1.78 Million | $16.82K | -0.009x | +96.11% |
| 2008-09-30 | $-1.09 Million | $265.45K | -0.242x | -175.20% |
| 2007-09-30 | $-1.50 Million | $-482.24K | 0.322x | -69.04% |
| 2006-09-30 | $-707.79K | $-737.05K | 1.041x | +123.12% |
| 2005-09-30 | $-1.02 Million | $-475.26K | 0.467x | +173.86% |
| 2004-09-30 | $261.96K | $-165.53K | -0.632x | -364.69% |
| 2003-09-30 | $1.92 Million | $458.82K | 0.239x | +3967.47% |
| 2002-09-30 | $3.21 Million | $18.81K | 0.006x | -53.73% |
| 2001-09-30 | $4.77 Million | $60.48K | 0.013x | +103.65% |
| 2000-09-30 | $5.58 Million | $-1.94 Million | -0.348x | -668.43% |
| 1999-09-30 | $4.90 Million | $300.00K | 0.061x | +54.59% |
| 1998-09-30 | $10.10 Million | $400.00K | 0.040x | +298.02% |
| 1997-09-30 | $10.00 Million | $-200.00K | -0.020x | -137.60% |
| 1996-09-30 | $9.40 Million | $500.00K | 0.053x | +116.84% |
| 1995-09-30 | $1.90 Million | $-600.00K | -0.316x | -113.16% |
| 1994-09-30 | $2.70 Million | $-400.00K | -0.148x | +37.45% |
| 1993-09-30 | $3.80 Million | $-900.00K | -0.237x | -- |